E Fund Management Co., Ltd. Day One Biopharmaceuticals, Inc. Transaction History

E Fund Management Co., Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$9.68 - $15.37 $4,278 - $6,793	442 Added 3.63%	12,618 $184,000
Q3 2023 Nov 13, 2023	SELL	$11.22 - $14.86 $38,877 - $51,489	-3,465 Reduced 22.15%	12,176 $149,000
Q2 2023 Aug 11, 2023	BUY	$11.74 - $14.47 $56,046 - $69,079	4,774 Added 43.93%	15,641 $187,000
Q1 2023 May 11, 2023	BUY	$12.75 - $23.41 $1,313 - $2,411	103 Added 0.96%	10,867 $145,000
Q4 2022 Feb 14, 2023	BUY	$18.77 - $22.0 $202,040 - $236,808	10,764 New	10,764 $232,000

178

84M

144K

218K

Ticker DAWN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,461,104
Market Cap $1.01B
Description
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.